Compagnie Lombard Odier SCmA’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-10,727
Closed -$86K 666
2017
Q4
$86K Buy
+10,727
New +$86K ﹤0.01% 487
2017
Q2
Sell
-826
Closed -$20K 759
2017
Q1
$20K Buy
+826
New +$20K ﹤0.01% 633